Transfer Factors: Properties, Mechanism of Action and Its Clinical Applications Ebook Tooltip

Afbeeldingen

Transfer Factors: Properties, Mechanism of Action and Its Clinical Applications

Artikel vergelijken

  • Engels
  • E-book
  • 9781662930027
  • 04 mei 2023
  • Adobe ePub
Alle productspecificaties
  • Je leest ebooks gemakkelijk op je Kobo e-reader, of op je smartphone of tablet met de bol.com Kobo app. Let op! Ebooks kunnen niet geannuleerd of geretourneerd worden.

Productbeschrijving

To date, transfer factors hold promise as one of the most exciting discovery in immunology and disease prevention. As the 21st century unfolds, these small molecules represent an important key to human health and well-being. Transfer factors are material present in dialysable leukocyte extracts capable of transferring cell-mediated immunity to pathogens. Transfer factors from one immune donor can be introduced into a non-immune recipient, potentially delivering an improved ability to fight threats to the recipient’s health. Similar to vaccines, transfer factors are prophylactic when administered prior to exposure to a pathogen.

This book is an overview of basic immunology and the concept of transfer factors derived from past and current scientific publications. In this book, the properties, mechanism of action, and clinical applications of transfer factors are described. Since their discovery, evidence suggests transfer factors play an important role as immune modulators in treating diseases associated with the defective function of cell-mediated immunity such as cancer, infectious diseases, etc.

The MF Plus Super Transfer Factor is then introduced including its function, characteristics, course, mode of administration, and advantages. The conclusion compiles research papers of transfer factor from years 2009 to 2020.

This book will interest researchers and scientists in fields such as immunology, molecular medicine, biomedicine, immunotherapy, pathology, microbiology, and oncology.

About the Author

Professor Dato’ Sri Dr. Mike K.S. Chan is a pioneer of Cellular and Cell Membrane Therapy in Europe and Asia since the early 1980’s. He founded one of the world’s largest researchers of Bio-Molecular Medicine based in Switzerland and Germany with a global presence in almost eighty countries. He has conducted more than 1,000 lectures, seminars, and symposiums worldwide in the fields of antiaging, cell regeneration, regenerative medicine, and stem-cell therapies.

Prof. Dato' Sri Dr. Michelle Wong Bi Fah, ND, PhD, is a scientist actively involved in research and development (R&D) work on stem cells focusing on Foetal Precursor Stem-Cell Therapy. She is the Co-Founder/Technical Advisor and Researcher of FCTI Inc. Her primary role is envisioning and devising a strategic roadmap for the organization's growth, especially in today's rapidly evolving business ecosystem. A prominent speaker, Dr. Wong presents at educational programs and global conferences on cell therapy and biological medicine for physicians and healthcare practitioners worldwide.

Dr. Patricia Pan is a researcher specializing in the fields of animal stem cells, clinical microbiology, environmental microbiology, and medical biotechnology and immunology. She holds a PhD in Biotechnology focusing on natural immunomodulators which augment the immune system to protect against infections. Dr. Pan lectured and trained medical laboratory technology students as a tutor, lecturer, and Head of School in the field of Medical Laboratory Technology. Lecture topics included clinical microbiology, immunology and serology, immunohematology and clinical parasitology. Mentored students achieved successful careers as medical laboratory technologists. She currently works as the Head of Research focusing on developing new research projects including protocol design, analysis, and results interpretation. She is also a prolific contributing writer of review and research articles in the field of regenerative medicine including stem cells biology, its mechanisms, and medical application. Dr. Pan currently monitors the progress of preclinical animal studies and clinical trials for Investigational New Drug (IND) submission.

Productspecificaties

Inhoud

Taal
en
Bindwijze
E-book
Oorspronkelijke releasedatum
04 mei 2023
Ebook Formaat
Adobe ePub

Betrokkenen

Hoofdauteur
Prof Dr Mike KS Chan
Tweede Auteur
Prof Dr Michelle Wong
Hoofduitgeverij
EUROPEAN WELLNESS ACADEMY

Lees mogelijkheden

Lees dit ebook op
Android (smartphone en tablet) | Kobo e-reader | Desktop (Mac en Windows) | iOS (smartphone en tablet) | Windows (smartphone en tablet)

Overige kenmerken

Studieboek
Nee

EAN

EAN
9781662930027

Je vindt dit artikel in

Categorieën
Nog geen reviews

Negatief, positief, neutraal: we zetten een review altijd online. We controleren wel eerst of ’ie voldoet aan onze reviewvoorwaarden en niet nep is. We controleren ook of ’ie is geschreven door iemand die het artikel heeft gekocht via bol.com en zetten dit er dan bij. De controles gebeuren automatisch, al kijken er soms mensen mee. Bol.com betaalt niet voor reviews. Als een reviewer door een andere partij is vergoed, staat dit in de review zelf.

Kies gewenste uitvoering

Bindwijze: E-book

Prijsinformatie

De prijs van dit product is 48 euro en 14 cent.
Direct beschikbaar
Verkoop door bol.com
  • E-book is direct beschikbaar na aankoop
  • E-books lezen is voordelig
  • Dag en nacht klantenservice
  • Veilig betalen

Recent bezochte artikelen

 

Lijst met gekozen artikelen om te vergelijken

Vergelijk artikelen